![Richard Archer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Archer
Geen lopende functies
Loopbaan van Richard Archer
Eerdere bekende functies van Richard Archer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Axordia Ltd.
![]() Axordia Ltd. Miscellaneous Commercial ServicesCommercial Services Axordia Ltd. develops human embryonic stem cell applications. Its applications include dry AMD, next generation stents, and GMP-compliant HESC lines. The company was founded by Peter W. Andrews and Harry Moore in 2001 and is headquartered in Sheffield, UK. | Voorzitter | - | 18-04-2013 |
Akubio Ltd.
![]() Akubio Ltd. Electronic Equipment/InstrumentsElectronic Technology Akubio Ltd. develops acoustic biosensor instruments. Its products are used in protein research and drug development. The company's technology based on quartz resonators delivers molecular identification and measurement of interactions in complex samples. Akubio was founded by Matthew A. Cooper in August 2001 and is headquartered in Cambridge, UK | Directeur/Bestuurslid | - | 31-05-2010 |
Statistieken
Internationaal
Verenigd Koninkrijk | 3 |
Operationeel
Director/Board Member | 1 |
Chairman | 1 |
Sectoraal
Electronic Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Akubio Ltd.
![]() Akubio Ltd. Electronic Equipment/InstrumentsElectronic Technology Akubio Ltd. develops acoustic biosensor instruments. Its products are used in protein research and drug development. The company's technology based on quartz resonators delivers molecular identification and measurement of interactions in complex samples. Akubio was founded by Matthew A. Cooper in August 2001 and is headquartered in Cambridge, UK | Electronic Technology |
Axordia Ltd.
![]() Axordia Ltd. Miscellaneous Commercial ServicesCommercial Services Axordia Ltd. develops human embryonic stem cell applications. Its applications include dry AMD, next generation stents, and GMP-compliant HESC lines. The company was founded by Peter W. Andrews and Harry Moore in 2001 and is headquartered in Sheffield, UK. | Commercial Services |
- Beurs
- Insiders
- Richard Archer
- Ervaring